Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trial

IntroductionBipolar disorder has a long depressive episode and high risk of suicide. In clinical practice, patients often show no response to pharmacotherapy, which results in prolongation of the depressive episode. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique expe...

Full description

Saved in:
Bibliographic Details
Main Authors: Takamasa Noda, Masako Nishikawa, Yuki Matsuda, Daisuke Hayashi, Shinsuke Kito
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1393605/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849767469453934592
author Takamasa Noda
Masako Nishikawa
Yuki Matsuda
Daisuke Hayashi
Shinsuke Kito
author_facet Takamasa Noda
Masako Nishikawa
Yuki Matsuda
Daisuke Hayashi
Shinsuke Kito
author_sort Takamasa Noda
collection DOAJ
description IntroductionBipolar disorder has a long depressive episode and high risk of suicide. In clinical practice, patients often show no response to pharmacotherapy, which results in prolongation of the depressive episode. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique expected to serve as a treatment option for bipolar depression. For bipolar depression, a meta-analysis suggested that low-frequency stimulation to the right prefrontal cortex was possibly effective. However, a medium or large sample, randomized, double blind, sham controlled study has not yet been performed.ObjectiveTo examine the efficacy and safety of 1-Hz rTMS to the right prefrontal cortex in patients with treatment-resistant bipolar depression. rTMS was approved by the Ministry of Health, Labor, and Welfare as a highly advanced medical technology on March 1, 2019.MethodsIn this multicenter, double-blind, randomized, sham stimulation-controlled trial for bipolar depression, patients will be individually allocated to active or sham stimulation plus usual medication and followed up for 6 months. The conditions of stimulation by the Mag Pro R30 transcranial magnetic stimulation device (Magventure) will be a frequency of 1-Hz, intensity of 120% motor threshold, and duration of 1800 seconds to the right prefrontal cortex 5 days a week for 4 weeks during the acute treatment period. The primary endpoint will be a total change in the Montgomery-Åsberg Depression Rating Scale score during the acute treatment period.DiscussionThe outcomes of this study will inform clinical practice for the treatment of bipolar depression.Clinical trial registrationhttps://jrct.niph.go.jp/latest-detail/jRCTs032180138, identifier jRCTs032180138.
format Article
id doaj-art-1e4e06ac30ca4621bbd522813b5736ab
institution DOAJ
issn 1664-0640
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj-art-1e4e06ac30ca4621bbd522813b5736ab2025-08-20T03:04:11ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402025-04-011610.3389/fpsyt.2025.13936051393605Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trialTakamasa Noda0Masako Nishikawa1Yuki Matsuda2Daisuke Hayashi3Shinsuke Kito4Department of Psychiatry, National Center Hospital of Neurology and Psychiatry, Tokyo, JapanClinical Research Support Center, The Jikei University School of Medicine, Tokyo, JapanDepartment of Psychiatry, The Jikei University School of Medicine, Tokyo, JapanDepartment of Psychiatry, National Center Hospital of Neurology and Psychiatry, Tokyo, JapanDepartment of Psychiatry, National Center Hospital of Neurology and Psychiatry, Tokyo, JapanIntroductionBipolar disorder has a long depressive episode and high risk of suicide. In clinical practice, patients often show no response to pharmacotherapy, which results in prolongation of the depressive episode. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique expected to serve as a treatment option for bipolar depression. For bipolar depression, a meta-analysis suggested that low-frequency stimulation to the right prefrontal cortex was possibly effective. However, a medium or large sample, randomized, double blind, sham controlled study has not yet been performed.ObjectiveTo examine the efficacy and safety of 1-Hz rTMS to the right prefrontal cortex in patients with treatment-resistant bipolar depression. rTMS was approved by the Ministry of Health, Labor, and Welfare as a highly advanced medical technology on March 1, 2019.MethodsIn this multicenter, double-blind, randomized, sham stimulation-controlled trial for bipolar depression, patients will be individually allocated to active or sham stimulation plus usual medication and followed up for 6 months. The conditions of stimulation by the Mag Pro R30 transcranial magnetic stimulation device (Magventure) will be a frequency of 1-Hz, intensity of 120% motor threshold, and duration of 1800 seconds to the right prefrontal cortex 5 days a week for 4 weeks during the acute treatment period. The primary endpoint will be a total change in the Montgomery-Åsberg Depression Rating Scale score during the acute treatment period.DiscussionThe outcomes of this study will inform clinical practice for the treatment of bipolar depression.Clinical trial registrationhttps://jrct.niph.go.jp/latest-detail/jRCTs032180138, identifier jRCTs032180138.https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1393605/fullbipolar depression (BD)rTMS (repetitive transcranial magnetic stimulation)low-frequency stimulation to the right prefrontal cortexdouble-blind randomized sham stimulation-controlled trialstudy protocol
spellingShingle Takamasa Noda
Masako Nishikawa
Yuki Matsuda
Daisuke Hayashi
Shinsuke Kito
Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trial
Frontiers in Psychiatry
bipolar depression (BD)
rTMS (repetitive transcranial magnetic stimulation)
low-frequency stimulation to the right prefrontal cortex
double-blind randomized sham stimulation-controlled trial
study protocol
title Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trial
title_full Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trial
title_fullStr Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trial
title_full_unstemmed Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trial
title_short Efficacy and safety of low-frequency repetitive transcranial magnetic stimulation for bipolar depression: a study protocol for a multicenter, double-blind, randomized, sham-controlled trial
title_sort efficacy and safety of low frequency repetitive transcranial magnetic stimulation for bipolar depression a study protocol for a multicenter double blind randomized sham controlled trial
topic bipolar depression (BD)
rTMS (repetitive transcranial magnetic stimulation)
low-frequency stimulation to the right prefrontal cortex
double-blind randomized sham stimulation-controlled trial
study protocol
url https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1393605/full
work_keys_str_mv AT takamasanoda efficacyandsafetyoflowfrequencyrepetitivetranscranialmagneticstimulationforbipolardepressionastudyprotocolforamulticenterdoubleblindrandomizedshamcontrolledtrial
AT masakonishikawa efficacyandsafetyoflowfrequencyrepetitivetranscranialmagneticstimulationforbipolardepressionastudyprotocolforamulticenterdoubleblindrandomizedshamcontrolledtrial
AT yukimatsuda efficacyandsafetyoflowfrequencyrepetitivetranscranialmagneticstimulationforbipolardepressionastudyprotocolforamulticenterdoubleblindrandomizedshamcontrolledtrial
AT daisukehayashi efficacyandsafetyoflowfrequencyrepetitivetranscranialmagneticstimulationforbipolardepressionastudyprotocolforamulticenterdoubleblindrandomizedshamcontrolledtrial
AT shinsukekito efficacyandsafetyoflowfrequencyrepetitivetranscranialmagneticstimulationforbipolardepressionastudyprotocolforamulticenterdoubleblindrandomizedshamcontrolledtrial